InvestorsHub Logo
Followers 21
Posts 635
Boards Moderated 0
Alias Born 11/08/2018

Re: Biobillionair post# 276804

Friday, 05/29/2020 2:28:34 AM

Friday, May 29, 2020 2:28:34 AM

Post# of 426389
Risks re injunction -
Costs of doing so - minor
Not getting one - generics don’t know / nor amarin know whether they will get injunction-but for generics to incur all costs incurred for launch to then get an injunction slapped on them and then losing appeal means they have spent a bucket of money for no gain - remember generics don’t have a patent life to try and profit over - they will be selling the product forever - so their intelligent move is to wait -the right commercial decision
Amarin not applying for an injunction now is intelligent .. applying now and losing the application is not - if generics do launch it may be a question of timing - for example if they launched a week before appeal hearing why bother ? - the appeal will resolve the issue (maybe it might just be a negative for generics in the appeal -they launched as though they were cock sure of winning )
And if generics launch and lose appeal - damages to boot to pay
Amarin applying and not getting injunction would send out another bad (wrongly perceived )signal to the market - (which would be over reaction share price drop)because the appeal is the crux decision that Amarin faces as to USA
Sometimes doing nothing is intelligent
Alm
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News